Chhb.Kl
CHHB.KL operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and products in this sector.
Business. CHHB.KL operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and products in this sector.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
CHHB.KL operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and products in this sector.
CHHB.KL's capital structure is characterized by a low debt-to-equity ratio of 0.07, indicating a conservative approach to leverage. However, the company's liquidity is rated as medium, and its current ratio of 0.85 suggests that it may struggle to meet short-term obligations with its current assets. The company's operating cash flow is positive at MYR 1.23 million, but this is significantly lower than the capital expenditure of MYR 2.76 million, indicating a net outflow of cash from operations.
In terms of profitability, CHHB.KL is currently unprofitable, with a net loss of MYR 41.89 million and an operating loss of MYR 30.82 million. The return on equity is -7.1%, and the return on assets is -4.36%, both of which are negative and suggest poor performance relative to its equity and asset base. These figures are likely below the industry median for healthcare facilities and services, indicating that the company is underperforming its peers in terms of profitability and returns.
CHHB.KL's revenue is not segmented by geographic regions or business lines in the provided data, so it is not possible to determine the geographic exposure or revenue concentration. However, the lack of segmentation data suggests that the company may have a concentrated revenue base, which could pose a risk if a particular market or product line underperforms.
The company's growth trajectory is not clearly defined in the provided data, as there are no specific numeric deltas or revenue history provided for the current or next fiscal year. The absence of growth data makes it difficult to assess the company's future performance or its ability to increase revenue and profitability.
The risk assessment for CHHB.KL indicates a medium liquidity risk and a low dilution risk. The company has a key flag indicating that its net cash is negative after subtracting total debt, which could affect its ability to fund operations and investments. The dilution risk is low, suggesting that the company is not expected to issue additional shares in the near term, which could help maintain shareholder value.
There are no recent events, such as filings or transcripts, provided in the data to indicate any significant changes in the company's operations or strategy. The absence of recent events suggests that the company may be in a stable but uneventful phase, with no major developments affecting its financial performance or market position.
- CHHB.KL is currently unprofitable with a net loss of MYR 41.89 million and an operating loss of MYR 30.82 million.
- The company has a low debt-to-equity ratio of 0.07, indicating a conservative capital structure.
- CHHB.KL's liquidity is rated as medium, and its current ratio of 0.85 suggests potential difficulties in meeting short-term obligations.
- The company's return on equity is -7.1%, and the return on assets is -4.36%, both of which are negative and indicate poor performance.
- The company's net cash is negative after subtracting total debt, which could affect its ability to fund operations and investments.
- margin_outlook_rationale: The company's current unprofitability and negative returns suggest a challenging margin outlook driven by operational inefficiencies and high costs.
- rd_outlook_rationale: There is no specific information provided about the company's research and development activities or their expected impact on future performance.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- CHHB.KL Market data — financials · 2026-05-27